These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 15786913)

  • 1. [The use of beta blockaders in chronic heart failure shows how important the application of evidence based medicine really is].
    Swedberg K; Skoglund I
    Lakartidningen; 2005 Feb 21-27; 102(8):580. PubMed ID: 15786913
    [No Abstract]   [Full Text] [Related]  

  • 2. [Beta-blockers in heart failure. From contraindicated therapy to the best documented one].
    Swedberg K
    Lakartidningen; 1999 Jun; 96(24):2940-2. PubMed ID: 10402795
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of chronic heart failure with beta-adrenoceptor antagonists. Guideline-based optimization with ERICA, a quality register].
    Antoni DH; Beuckelmann D; Hambrecht R; Nowak F; Schuchert D; Schwinger RH
    Dtsch Med Wochenschr; 2002 Nov; 127(46):2459-63. PubMed ID: 12432488
    [No Abstract]   [Full Text] [Related]  

  • 4. Beta-blockers and heart failure in older people.
    Le Couteur DG; Bailey L; Naganathan V
    Eur Heart J; 2006 Apr; 27(7):887-8; author reply 888-9. PubMed ID: 16478748
    [No Abstract]   [Full Text] [Related]  

  • 5. Evidence-based drug treatment of heart failure.
    Wasson S; Fleming D; Reddy HK
    Mo Med; 2005; 102(6):540-8; quiz 548-9. PubMed ID: 16355640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials: a report from the Euro Heart Survey on Heart Failure.
    Lenzen MJ; Boersma E; Reimer WJ; Balk AH; Komajda M; Swedberg K; Follath F; Jimenez-Navarro M; Simoons ML; Cleland JG
    Eur Heart J; 2005 Dec; 26(24):2706-13. PubMed ID: 16183692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-blocker therapy for patients with ventricular heart failure and reduced systolic function.
    Giles TD
    Postgrad Med; 2003 Dec; 114(6 Suppl Role):18-29. PubMed ID: 19667666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Possibilities and problems of using beta-adrenoblockers in chronic heart failure].
    Lopatin IuM; Gkhani P; Mareev VIu; Belenkov IuN
    Ter Arkh; 1993; 65(9):85-8. PubMed ID: 7905673
    [No Abstract]   [Full Text] [Related]  

  • 9. [Internal medicine using therapy beta receptor blockaders, especially practolol].
    Kutscha W
    Z Prakt Anasth Wiederbeleb Intensivther; 1972 Dec; 7(6):360-2. PubMed ID: 4405590
    [No Abstract]   [Full Text] [Related]  

  • 10. About "Resting heart rate does not reflect the degree of beta-blockade in subjects with heart failure on chronic beta-blocker therapy".
    Carvalho VO
    Cardiovasc Ther; 2009; 27(3):221. PubMed ID: 19689621
    [No Abstract]   [Full Text] [Related]  

  • 11. [Chronic left heart failure. A focus on the pathogenetic basis of medical treatment].
    Novosel MK; Haghfelt TH
    Ugeskr Laeger; 2006 May; 168(19):1854-6. PubMed ID: 16756801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical analysis of the effect of beta-blocker receptors in patients with chronic heart failure].
    Li B; Hu YM; Su XY; Hu YL
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Apr; 19(4):251-2. PubMed ID: 17448290
    [No Abstract]   [Full Text] [Related]  

  • 13. [Elderly heart failure patients and the role of beta-blocker therapy].
    Middeljans-Tijssen CW; Jansen RW
    Tijdschr Gerontol Geriatr; 2006 Apr; 37(2):67-77. PubMed ID: 16704019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is the level of evidence for the use of beta-blockers in acute myocardial infarction satisfactory enough?
    Mrdovic IB
    Eur Heart J; 2006 Jan; 27(1):118-9; author reply 119. PubMed ID: 16272212
    [No Abstract]   [Full Text] [Related]  

  • 15. Combination therapy with beta-adrenergic receptor antagonists and phosphodiesterase inhibitors for chronic heart failure.
    Van Tassell BW; Radwanski P; Movsesian M; Munger MA
    Pharmacotherapy; 2008 Dec; 28(12):1523-30. PubMed ID: 19025433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Beta-blocker prescription and chronic obstructive pulmonary disease].
    Ollivier R; Donal E; Delaval P; Daubert JC; Mabo P
    Ann Cardiol Angeiol (Paris); 2007 Nov; 56(5):231-6. PubMed ID: 17854758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How well are chronic heart failure patients being managed?
    Fonarow GC
    Rev Cardiovasc Med; 2006; 7 Suppl 1():S3-11. PubMed ID: 16955055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Do women receive as good treatment for heart diseases as men?].
    Risøe C; Graff-Iversen S
    Tidsskr Nor Laegeforen; 2006 Mar; 126(6):785-7. PubMed ID: 16541174
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of neurohormonal modulators in heart failure with relatively preserved systolic function.
    Rapp JA; Gheorghiade M
    Heart Fail Clin; 2005 Apr; 1(1):77-93. PubMed ID: 17386836
    [No Abstract]   [Full Text] [Related]  

  • 20. Switching to evidence-based once-daily beta-blockers for improved adherence to medication across the continuum of post-myocardial infarction left ventricular dysfunction and heart failure.
    Abraham WT
    Congest Heart Fail; 2008; 14(5):272-80. PubMed ID: 18983291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.